Abstract
The pipelle has become the sampling tool of choice for histological detection of endometrial adenocarcinoma. Some practitioners still prefer cytological sampling. The distal extremity of the pipelle has been modified to allow removal of both types of samples simultaneously The aim of this preliminary study was to evaluate the feasibility of this method.
A positive agreement between histological and cytological results was found in 10 out of the 12 cases examined, among which an adenocarcinoma was positively defected. A prospective study on larger size must confirm these first findings.
The new modified pipelle (Pipelle Mark II) offers a possible approach for reduction of false negatives.